Report cover image

Global Psychedelic Drugs Market - Industry Trends and Forecast to 2029

Publisher Data Bridge Market Research
Published May 01, 2022
Length 296 Pages
SKU # DAABD17330401

Description

Global Psychedelic Drugs Market - Industry Trends and Forecast to 2029

Global psychedelic drugs market is projected to register a substantial CAGR of 13.3% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.

Market Segmentation:
Global Psychedelic Drugs Market, By Source (Synthetic & Natural), Type (Empathogens, Dissociatives & Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others), Route of Administration (Oral, Inhalation, Injectable), End User (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy), Country (North America, Europe, Asia-Pacific, Middle East and Africa and South America) Industry Trends and Forecast to 2029

Some of the major factors contributing to the growth of the global psychedylic drugs market are:
• Growing acceptance of psychedelic drugs for treating depression
• Increasing Prevalence Of Depression And Mental Disorders

Market Players
The key market players for global psychedelic drugs market are listed below:
• Jazz Pharmaceuticals, Inc.
• Janssen Global Services, LLC (a subsidiary of Johnson & Johnson Services, Inc.)
• Hikma Pharmaceuticals PLC
• COMPASS
• Verrian
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd
• Avadel
• Celon Pharma SA.
• Cybin Corp.
• GH Research
• Entheon Biomedical Corp
• PharmaTher Holdings Ltd.
• NRx Pharmaceuticals, Inc.
• usonainstitute.org

Table of Contents

296 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Global Psychedelic Drugs Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market End User Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insight
4.1 Pipeline Analysis
4.2 Pestel Analysis
4.3 Porter's Five Forces Model
5 Regulatory Framework: Global Psychedelic Drugs Market
5.1 Regulatory Scenario In The U.S.
5.2 Regulatory Scenario In The U.K.
5.3 Regulatory Scenario In India
5.4 Regulatory Scenario In Uae
5.5 Regulatory Scenario In Africa
5.6 Regulatory Scenario In Brazil
6 Market Overview
6.1 Drivers
6.1.1 Growing Acceptance Of Psychedelic Drugs To Treat Depression
6.1.2 Increasing Prevalence Of Depression And Mental Disorders
6.1.3 Rising Awareness Toward Mental Health
6.1.4 Ongoing Clinical Trials
6.1.5 Rise In Product Approvals
6.2 Restraints
6.2.1 Stringent Regulations For Psychedelic Drugs
6.2.2 High Cost Of Psychedelic Drugs
6.2.3 Patent Expiry Of Psychedelic Drugs
6.3 Opportunities
6.3.1 Increasing R&D Activities In Psychedelic Drugs
6.3.2 Breakthrough Therapy Designation By Regulatory Authority
6.3.3 Upcoming Rehabilitation Centers
6.3.4 Availability Of Certified Healthcare Professionals
6.4 Challenges
6.4.1 Side Effects Associated With Psychedelic Drugs
6.4.2 Rise In Illegal Alternatives
6.4.3 Availability Of Other Treatment Options
7 Covid-19 Impact On The Global Psychedelic Drugs Market
7.1 Impact On Price
7.2 Impact On Demand
7.3 Impact On Supply Chain
7.4 Strategic Decisions For Manufacturers
7.5 Conclusion
8 Global Psychedelic Drugs Market, By Type
8.1 Overview
8.2 Empathogens
8.3 Dissociatives
8.4 Others
9 Global Psychedelic Drugs Market, By Source
9.1 Overview
9.2 Synthetic
9.3 Natural
10 Global Psychedelic Drugs Market, By Drugs
10.1 Overview
10.2 Gamma-hydroxybutyric Acid
10.3 Ketamine
10.4 Psilocybin
10.5 Others
11 Global Psychedelic Drugs Market, By Application
11.1 Overview
11.2 Narcolepsy
11.3 Treatment Resistant Depression
11.4 Major Depressive Disorder
11.5 Opiate Addiction
11.6 Post-traumatic Stress Disorder
11.7 Others
12 Global Psychedelic Drugs Market, By Route Of Administration
12.1 Overview
12.2 Oral
12.3 Inhalation
12.4 Injectable
13 Global Psychedelic Drugs Market, By End User
13.1 Overview
13.2 Hospitals
13.3 Specialty Clinics
13.4 Homecare
13.5 Others
14 Global Psychedelic Drugs Market, By Distribution Channel
14.1 Overview
14.2 Hospitals Pharmacy
14.3 Retail Pharmacy
14.4 Online Pharmacy
15 Global Psychedelic Drugs Market, By Region
15.1 Overview
15.2 North America
15.2.1 U.S.
15.2.2 Canada
15.2.3 Mexico
15.3 Europe
15.3.1 Germany
15.3.2 U.K.
15.3.3 France
15.3.4 Italy
15.3.5 Spain
15.3.6 Russia
15.3.7 Poland
15.3.8 Switzerland
15.3.9 Netherlands
15.3.10 Hungary
15.3.11 Austria
15.3.12 Norway
15.3.13 Ireland
15.3.14 Belgium
15.3.15 Lithuania
15.3.16 Rest Of Europe
15.4 Asia-pacific
15.4.1 India
15.4.2 Australia
15.4.3 South Korea
15.4.4 Singapore
15.4.5 Malaysia
15.5 Middle East & Africa
15.5.1 Saudi Arabia
15.5.2 Israel
15.5.3 Egypt
15.5.4 Uae
15.5.5 South Africa
15.6 South America
15.6.1 Brazil
15.6.2 Argentina
15.6.3 Rest Of South America
16 Global Psychedelic Drugs Market: Company Landscape
16.1 Company Share Analysis: Global
16.2 Company Share Analysis: North America
16.3 Company Share Analysis: Europe
16.4 Company Share Analysis: Asia-pacific
17 Swot Analysis
18 Company Profile
18.1 Jazz Pharmaceuticals, Inc.
18.1.1 Company Snapshot
18.1.2 Revenue Analysis
18.1.3 Company Share Analysis
18.1.4 Product Portfolio
18.1.5 Recent Developments
18.2 Pfizer Inc.
18.2.1 Company Snapshot
18.2.2 Revenue Analysis
18.2.3 Company Share Analysis
18.2.4 Product Portfolio
18.2.5 Recent Developments
18.3 F. Hoffmann- La Roche Ltd
18.3.1 Company Snapshot
18.3.2 Revenue Analysis
18.3.3 Company Share Analysis
18.3.4 Product Portfolio
18.3.5 Recent Development
18.4 Janssen Global Services, Llc (A Subsidiary Of Johnson & Johnson Services, Inc.)
18.4.1 Company Snapshot
18.4.2 Company Share Analysis
18.4.3 Product Portfolio
18.4.4 Recent Development
18.5 Avadel
18.5.1 Company Snapshot
18.5.2 Product Portfolio
18.5.3 Recent Development
18.6 Celon Pharma Sa
18.6.1 Company Snapshot
18.6.2 Product Portfolio
18.6.3 Recent Development
18.7 Compass
18.7.1 Company Snapshot
18.7.2 Product Portfolio
18.7.3 Recent Developments
18.8 Cybin Corp.
18.8.1 Company Snapshot
18.8.2 Product Portfolio
18.8.3 Recent Developments
18.9 Entheon Biomedical Corp
18.9.1 Company Snapshot
18.9.2 Product Portfolio
18.9.3 Recent Development
18.10 Gh Research
18.10.1 Company Snapshot
18.10.2 Product Portfolio
18.10.3 Recent Development
18.11 Hikma Pharmaceuticals Plc
18.11.1 Company Snapshot
18.11.2 Revenue Analysis
18.11.3 Product Portfolio
18.11.4 Recent Developments
18.12 Nrx Pharmaceuticals, Inc.
18.12.1 Company Snapshot
18.12.2 Product Portfolio
18.12.3 Recent Development
18.13 Pharmather Holdings Ltd.
18.13.1 Company Snapshot
18.13.2 Product Portfolio
18.13.3 Recent Development
18.14 Verrian
18.14.1 Company Snapshot
18.14.2 Product Portfolio
18.14.3 Recent Development
18.15 Usonainstitute.Org
18.15.1 Company Snapshot
18.15.2 Product Portfolio
18.15.3 Recent Development
19 Questionnaire
20 Related Reports
List Of Figures
Figure 1 Global Psychedelic Drugs Market: Segmentation
Figure 2 Global Psychedelic Drugs Market : Data Triangulation
Figure 3 Global Psychedelic Drugs Market: Droc Analysis
Figure 4 Global Psychedelic Drugs Market: Global Vs Regional Market Analysis
Figure 5 Global Psychedelic Drugs Market: Company Research Analysis
Figure 6 Global Psychedelic Drugs Market: Multivariate Modelling
Figure 7 Global Psychedelic Drugs Market: Interview Demographics
Figure 8 Global Psychedelic Drugs Market: Dbmr Market Position Grid
Figure 9 Global Psychedelic Drugs Market: End User Coverage Grid
Figure 10 Global Psychedelic Drugs Market: Vendor Share Analysis
Figure 11 Global Psychedelic Drugs Market: Segmentation
Figure 12 North America Is Expected To Dominate The Global Psychedelic Drugs Market Growing With The Highest Cagr In The Forecast Period Of 2022 To 2029
Figure 13 Rising Awareness Towards Merantal Health Driving The Global Psychedelic Drugs Market In The Forecast Period Of 2022 To 2029
Figure 14 Empathogens Segment Is Expected To Account For The Largest Share Of The Global Psychedelic Drugs Market In 2022 & 2029
Figure 15 North America Is The Fastest Growing Market For Psychedelic Drugs Manufacturers In The Forecast Period Of 2022 To 2029
Figure 16 Drivers, Restraints, Opportunities, And Challenges Of The Global Psychedelic Drugs Market
Figure 17 Mental Illness Among The U.S. Adults, In 2020, (In %), By Demographic Groups
Figure 18 Mental Illness Treatment Rates Among The U.S. Adults, In 2020, (In %), By Demographic Groups
Figure 19 Mental Illness Treatment Rates Among The U.S. Adults, In 2020, (In %), By Gender
Figure 20 Global Psychedelic Drugs Market: By Type, 2021
Figure 21 Global Psychedelic Drugs Market: By Type, 2022-2029 (Usd Million)
Figure 22 Global Psychedelic Drugs Market: By Type, Cagr (2022-2029)
Figure 23 Global Psychedelic Drugs Market: By Type, Lifeline Curve
Figure 24 Global Psychedelic Drugs Market: By Source, 2021
Figure 25 Global Psychedelic Drugs Market: By Source, 2022-2029 (Usd Million)
Figure 26 Global Psychedelic Drugs Market: By Source, Cagr (2022-2029)
Figure 27 Global Psychedelic Drugs Market: By Source, Lifeline Curve
Figure 28 Global Psychedelic Drugs Market: By Drugs, 2021
Figure 29 Global Psychedelic Drugs Market: By Drugs, 2022-2029 (Usd Million)
Figure 30 Global Psychedelic Drugs Market: By Drugs, Cagr (2022-2029)
Figure 31 Global Psychedelic Drugs Market: By Drugs, Lifeline Curve
Figure 32 Global Psychedelic Drugs Market: By Application, 2021
Figure 33 Global Psychedelic Drugs Market: By Application, 2022-2029 (Usd Million)
Figure 34 Global Psychedelic Drugs Market: By Application, Cagr (2022-2029)
Figure 35 Global Psychedelic Drugs Market: By Application, Lifeline Curve
Figure 36 Global Psychedelic Drugs Market: By Route Of Administration, 2021
Figure 37 Global Psychedelic Drugs Market: By Route Of Administration, 2022-2029 (Usd Million)
Figure 38 Global Psychedelic Drugs Market: By Route Of Administration, Cagr (2022-2029)
Figure 39 Global Psychedelic Drugs Market: By Route Of Administration, Lifeline Curve
Figure 40 Global Psychedelic Drugs Market: By End User, 2021
Figure 41 Global Psychedelic Drugs Market: By End User, 2022-2029 (Usd Million)
Figure 42 Global Psychedelic Drugs Market: By End User, Cagr (2022-2029)
Figure 43 Global Psychedelic Drugs Market: By End User, Lifeline Curve
Figure 44 Global Psychedelic Drugs Market: By Distribution Channel, 2021
Figure 45 Global Psychedelic Drugs Market: By Distribution Channel, 2022-2029 (Usd Million)
Figure 46 Global Psychedelic Drugs Market: By Distribution Channel, Cagr (2022-2029)
Figure 47 Global Psychedelic Drugs Market: By Distribution Channel, Lifeline Curve
Figure 48 Global Psychedelic Drugs Market: Snapshot (2021)
Figure 49 Global Psychedelic Drugs Market: By Region (2021)
Figure 50 Global Psychedelic Drugs Market: By Region (2022 & 2029)
Figure 51 Global Psychedelic Drugs Market: By Region (2021 & 2029)
Figure 52 Global Psychedelic Drugs Market: By Type (2022-2029)
Figure 53 North America Psychedelic Drugs Market: Snapshot (2021)
Figure 54 North America Psychedelic Drugs Market: By Country (2021)
Figure 55 North America Psychedelic Drugs Market: By Country (2022 & 2029)
Figure 56 North America Psychedelic Drugs Market: By Country (2021 & 2029)
Figure 57 North America Psychedelic Drugs Market: By Type (2022-2029)
Figure 58 Europe Psychedelic Drugs Market: Snapshot (2021)
Figure 59 Europe Psychedelic Drugs Market: By Country (2021)
Figure 60 Europe Psychedelic Drugs Market: By Country (2022 & 2029)
Figure 61 Europe Psychedelic Drugs Market: By Country (2021 & 2029)
Figure 62 Europe Psychedelic Drugs Market: By Type (2022-2029)
Figure 63 Asia-pacific Psychedelic Drugs Market: Snapshot (2021)
Figure 64 Asia-pacific Psychedelic Drugs Market: By Country (2021)
Figure 65 Asia-pacific Psychedelic Drugs Market: By Country (2022 & 2029)
Figure 66 Asia-pacific Psychedelic Drugs Market: By Country (2021 & 2029)
Figure 67 Asia-pacific Psychedelic Drugs Market: By Type (2022-2029)
Figure 68 Middle East & Africa Psychedelic Drugs Market: Snapshot (2021)
Figure 69 Middle East & Africa Psychedelic Drugs Market: By Country (2021)
Figure 70 Middle East & Africa Psychedelic Drugs Market: By Country (2022 & 2029)
Figure 71 Middle East & Africa Psychedelic Drugs Market: By Country (2021 & 2029)
Figure 72 Middle East & Africa Psychedelic Drugs Market: By Type (2022-2029)
Figure 73 South America Psychedelic Drugs Market: Snapshot (2021)
Figure 74 South America Psychedelic Drugs Market: By Country (2021)
Figure 75 South America Psychedelic Drugs Market: By Country (2022 & 2029)
Figure 76 South America Psychedelic Drugs Market: By Country (2021 & 2029)
Figure 77 South America Psychedelic Drugs Market: By Type (2022-2029)
Figure 78 Global Psychedelic Drugs Market: Company Share 2021 (%)
Figure 79 North America Psychedelic Drugs Market: Company Share 2021 (%)
Figure 80 Europe Psychedelic Drugs Market: Company Share 2021 (%)
Figure 81 Asia-pacific Psychedelic Drugs Market: Company Share 2021 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us